1. Home
  2. DLTH vs CRDL Comparison

DLTH vs CRDL Comparison

Compare DLTH & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Duluth Holdings Inc. Class B

DLTH

Duluth Holdings Inc. Class B

HOLD

Current Price

$2.94

Market Cap

121.1M

ML Signal

HOLD

Logo Cardiol Therapeutics Inc.

CRDL

Cardiol Therapeutics Inc.

HOLD

Current Price

$1.07

Market Cap

97.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLTH
CRDL
Founded
1989
2017
Country
United States
Canada
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
121.1M
97.3M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
DLTH
CRDL
Price
$2.94
$1.07
Analyst Decision
Buy
Strong Buy
Analyst Count
1
2
Target Price
$7.00
$9.00
AVG Volume (30 Days)
79.2K
691.7K
Earning Date
12-16-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$602,746,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.24
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.58
$0.77
52 Week High
$4.66
$1.59

Technical Indicators

Market Signals
Indicator
DLTH
CRDL
Relative Strength Index (RSI) 44.54 55.68
Support Level $2.86 $0.88
Resistance Level $3.57 $1.12
Average True Range (ATR) 0.23 0.08
MACD -0.03 0.02
Stochastic Oscillator 7.04 83.33

Price Performance

Historical Comparison
DLTH
CRDL

About DLTH Duluth Holdings Inc. Class B

Duluth Holdings Inc is an apparel brand in the United States. The company offers shirts, pants, and casual wear for men and women under brands like Alaskan Hardgear, Armachillo, Ballroom, Cab Commander, Crouch Gusset, Dry on the Fly, Duluth Trading Co, Duluthflex, Fire Hose, Longtail T, No Polo Shirt, No Yank, Wild Boar, and others. The Company's revenue consists of the sale of apparel, footwear, and hard goods. The company operates in a single operating segment.

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

Share on Social Networks: